Treatment with an antibody of GCGR promoted beta-cell survival, improved the formation of functional beta-cell mass, and produced insulin-positive cells from cell precursors in NOD mice, a mouse model of T1D [66]. This evidence concerns the gene INS and type 1 diabetes mellitus.